Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
well, just an observation from my viewpoint...what one calls trading, another calls tanking since it was posted here...and I thought you weren't going to comment?
no need to, as it has dropped .01 since it was posted, lol
usual sell off on its highs from a post on here....usually whenever I see a Q posted on here, it tanks immediately
FRCMQ tanker here?
ROHI " wall " at .75 is fake and will go fast, ARCA been buying all day !!!
Man, what a stock this hidden gem is, I keep adding here....can't help myself !!!.....I told you all .70s by today and $1 by EOW !!!
ROHI, what a sweet play ask now .75, after that, cleared for $1 ++
serious dumping tomorrow on GETA....i hope they all GETA good exit point, then GETA good stock to replace it with
ROHI closed at HOD today, watch for $1 by weeks end, sweet chart
Just saw on Fox news ( fair and balanced ) that the tsunami warning was called off
now THERE was a good old boy who knew how to work the PR machine, as well as the social networking sites...LOL
is old Rufus still in the can...?
stuckholders 'll have to GETA a doctor by days end
Nobody beat old Rufus Harris
and the floods we got here in the Northeast too....the Libs probably blame it all on Bush
7.8 magnitude hits Indonesia
man, i surely got lucky for once on this one, best of luck to everyone here, I hope it works out for you all
wow, I got out of this one in time, sorry guys for the RS news
prnewswire.com or businesswire.com usually have news out fairly quick, though, I assume there are better sources than them
Holy shitt, when did that come out?.....i got out break even before the close
LOL...
ROHI .69 bell buy !!!
ROHI bid UT asked jumped to .69 easy .70s tomorrow and into $1 + range, EOW, imo
ALNS also a Microsoft Gold Partner
GETA breaks .085 and all hellz gonna break loose
GETA, fake wall there at .085
GETA, looks like .085 break and she's cleared for .10+ today
morning, ticker CHINA up .08 this morning, PM
ticker CHINA off and running this morning, PM up .08
Thanks for checking in, looking like ROHI could hit the .70s today, and possibly run to $1 by weeks end
Gotta love it when a pumper starts off his post by saying..." guys, I'm gonna be honest"
janiceshell is always in the thick of things, lol
CFW news AH
Cano Announces Mid-Year Fiscal 2010 Reserves
FORT WORTH, Texas--(BUSINESS WIRE)--Cano Petroleum, Inc. (NYSE Amex:CFW) today announced the results of a mid-year Fiscal 2010 Reserves review as prepared by Haas Petroleum Engineering Services, Inc. (Haas), its new independent petroleum engineer. Haas prepared 100% of the reserves for the properties. The Company replaced approximately 300% of estimated mid-year 2010 fiscal year production of 197.5 MBOE at an estimated reserve replacement cost of $15.84/BOE (including extensions and discoveries, excluding asset sales and production, and capital expenditures of $9.4 million). Over a two-and-one-half-year period, Cano had an estimated reserve replacement cost of $16.30/BOE.
Haas estimates Cano’s proved oil and gas reserves at December 31, 2009 to be 43.0 MMBOE, of which Proved Developed reserves were 8.8 MMBOE, down 6.3% as compared to 10.1 MMBOE at June 30, 2009, including property sales (510.6 MBOE) and production (197.5 MBOE). Reserves by property are as follows:
(in MBOE) FY 2009 Mid-Year 2010
Properties PDP PDNP PUD Proved PDP PDNP PUD Proved
Panhandle 3,440 - 25,433 28,873 2,462 383 20,990 23,835
Cato 1,858 530 13,582 15,970 1,095 724 13,216 15,035
Nowata 1,547 - - 1,547 1,584 53 - 1,637
Davenport 744 565 - 1,309 685 507 - 1,192
Desdemona 147 1,251 - 1,398 419 888 16 1,323
Total 7,736 2,346 39,015 49,097 6,245 2,555 34,222 43,022
Proved reserves declined 10.9%, net of asset sales and production, to 43.0 MMBOE. The majority of the reduction was due to a reduction in the PUD waterflood secondary to primary ratio at 15 of our 33 leases in the Panhandle Properties. All reserves associated with the Panhandle PUD reduction were reclassified into the probable reserve category. A divestiture at our Panhandle properties (containing 18 gas wells and one oil well) accounted for a reduction in PDP reserves of 510.6 MBOE. The sale was closed in January 2010, with an effective date of December 31, 2009. Net of the PUD reclassification and asset sales at the Panhandle Properties, all other Proved reserves declined 2.1%.
The estimates above do not include the effects of the SEC’s final rule, “Modernization of Oil and Gas Reporting,” issued in December 2008. This final rule is effective for annual reports on Forms 10-K for years ending on or after December 31, 2009. Haas utilized pricing at December 31, 2009 of $79.39 per barrel of oil and $5.82 per mcf of gas. Since early adoption of the final rule is prohibited, the final rule will be fully applied in the Company’s annual report on Form 10-K for the year ending June 30.
Oil reserves account for 77% (versus 79% at June 30, 2009) of Proved reserves and Proved Developed reserves account for 20% (versus 21% at June 30, 2009) of Proved reserves. Pre-tax PV-10 of our Proved reserves as of December 31, 2009 is $513.4 million (versus $471.3 million at June 30, 2009), of which $99.7 million is associated with Proved Developed reserves (versus $78.4 million at June 30, 2009).
The 593.0 MBOE of Extensions and Discoveries include newly identified behind-pipe opportunities at the Cato and Panhandle Properties. Additionally, approximately 311 MBOE of previously categorized PDNP reserves at Desdemona were reclassified to PDP as we re-activated prior shut-in Duke Sand gas production.
Summary of Changes in Proved Reserves MBOE
Reserves at June 30, 2009 49,097
Extensions and Discoveries 593
Producing Property Sales (511 )
Forecast Revisions (5,959 )
Estimated Production (198 )
Reserves at December 31, 2009 43,022
Reserve replacement is calculated by dividing the sum of reserve extensions, discoveries and acquisitions by production. Reserve replacement cost is calculated by dividing the sum of reserve extensions, discoveries and acquisitions by capital expenditures.
ABOUT CANO PETROLEUM:
Cano Petroleum Inc. is an independent Texas-based energy producer with properties in the midcontinent region of the United States. Led by an experienced management team, Cano’s primary focus is on increasing domestic production from proven fields using enhanced recovery methods. Cano trades on the American Stock Exchange under the ticker symbol CFW. Additional information is available at www.canopetro.com.
Safe-Harbor Statement -- Except for the historical information contained herein, the matters set forth in this news release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends that all such statements be subject to the “safe-harbor” provisions of those Acts. Many important risks, factors and conditions may cause the Company’s actual results to differ materially from those discussed in any such forward-looking statement. These risks include, but are not limited to, estimates or forecasts of reserves, estimates or forecasts of production, future commodity prices, exchange rates, interest rates, geological and political risks, drilling risks, product demand, transportation restrictions, the ability of Cano Petroleum, Inc. to obtain additional capital, and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission. The historical results achieved by the Company are not necessarily indicative of its future prospects. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts
Cano Petroleum, Inc.
Ben Daitch, 877-698-0900
Senior Vice President & CFO
INFO@canopetro.com
MVIS up nice AH on todays news
DYAX news AH
Dyax Announces Underwriter’s Exercise of Over-allotment Option
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that Jefferies & Company, Inc. exercised in full its over-allotment option to purchase an additional 2,550,000 shares of the Company’s common stock at a public offering price of $3.25 per share. The over-allotment option was granted to the underwriters by Dyax in connection with its recent offering of common stock. The exercise of the option brings the aggregate net proceeds from the offering to approximately $59.6 million. The sale of the additional shares closed on April 5, 2010.
Jefferies & Company, Inc. acted as the sole book-running manager of the offering with Needham & Company, LLC acting as the co-lead manager.
Dyax intends to use the net proceeds from this offering to fund commercialization and distribution activities for KALBITOR® (ecallantide), its lead product for the treatment of acute attacks for hereditary angioedema, to fund other research and preclinical development activities, and for general corporate purposes.
A registration statement relating to the shares of Dyax common stock being offered has been filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”). A final prospectus supplement related to the offering has been filed with the SEC and is available on the SEC’s website at http://www.sec.gov. Copies of the final prospectus supplement and related prospectus may be obtained from Jefferies & Company, Inc., Attention: Syndicate Prospectus Department, 520 Madison Avenue, New York, NY, 10022 or at (888) 449-2342. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Dyax
Dyax is a fully integrated biopharmaceutical company focused on discovering, developing and commercializing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. Dyax’s first product, KALBITOR® (ecallantide), is available in the United States for the treatment of acute attacks of hereditary angioedema in patients 16 years of age and older.
Dyax’s lead product candidate is DX-88, a recombinant, small protein that is being evaluated for its therapeutic potential in other angioedema indications (ACE inhibitor-induced and acquired angioedemas). DX-88 is also being evaluated through Dyax’s partner, Fovea Pharmaceuticals (sanofi aventis), in a Phase 1 trial for retinal vein occlusion-induced macular edema.
DX-88 and other compounds in Dyax’s pipeline were identified using its patented phage display technology, which rapidly selects compounds that bind with high affinity and specificity to therapeutic targets. Dyax leverages this technology broadly with over 70 revenue generating licenses and collaborations for therapeutic discovery, as well as in non-core areas such as affinity separations, diagnostic imaging, and research reagents. Dyax is headquartered in Cambridge, Massachusetts. For online information about Dyax Corp., please visit www.dyax.com.
Dyax and the Dyax logo are registered trademarks of Dyax Corp.
Contacts
Dyax Corp.
George Migausky, 617-250-5733
Executive Vice President
and Chief Financial Officer
gmigausky@dyax.com
or
Nicole Jones, 617-250-5744
Director, Investor Relations and
Corporate Communications
njones@dyax.com
ROHI .65s almost cleared, ARCA at .70 will run away fast
ROHI, .65s almost gone
JOEZ could run huge AH
ROHI ask getting spanked
ROHI, would not be surprised to see it close over .70 today and over $1 EOW